RCM
ACAD icon

RA Capital Management’s Acadia Pharmaceuticals ACAD Stock Holding History

RA Capital Management’s Portfolio ACAD Stock Details ACAD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-27,300
Closed -$1.14M – 48
2015
Q2 		$1.14M Hold
27,300
– – 0.12% 49
2015
Q1 		$890K Hold
27,300
– – 0.1% 54
2014
Q4 		$867K Sell
27,300
-2,700
-9% -$76.6K 0.11% 47
2014
Q3 		$743K Buy
+30,000
New +$702K 0.12% 44
2014
Q2 		– Sell
-250,000
Closed -$5.22M – 29
2014
Q1 		$6.08M Sell
250,000
-919,898
-79% -$23.3M 0.62% 29
2013
Q4 		$29.2M Sell
1,169,898
-865,612
-43% -$20.4M 4.51% 11
2013
Q3 		$55.9M Sell
2,035,510
-4,494,300
-69% -$94M 7.72% 4
2013
Q2 		$119M Buy
+6,529,810
New +$89.9M 19.24% 1

Other funds holding ACAD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
WRF
Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return